SLDB Berita Valas

Solid Biosciences Says FDA Grants Fast Track Designation For Gene Therapy Candidate SGT-003

Life sciences company Solid Biosciences Inc. (SLDB) announced Thursday that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for SGT-003, the company's next-generation Duchenne muscular dystrophy gene therapy candidate.

RTTNews | 629 days ago

Solid Biosciences Appoints Kevin Tan As New CFO

Life sciences company Solid Biosciences Inc. (SLDB) announced Monday the appointment of Kevin Tan, a seasoned industry professional, as Chief Financial Officer.

RTTNews | 962 days ago

Terms | Privacy | Site Map | Site Map Calendar

HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.

EURUSD	1.16376	GBPUSD	1.34952	AUDUSD	0.65146
USDJPY	147.259	USDCAD	1.37802	USDCHF	0.80147